How does the Written Opinion relate to the International Preliminary Report on Patentability?
The Written Opinion of the International Searching Authority has a direct relationship with the International Preliminary Report on Patentability (IPRP), as explained in MPEP 1845: “The written opinion is transmitted to the designated offices in the form of an international preliminary report on patentability if no international preliminary examination report is established under Chapter II…
Read MoreWhat is the purpose of the Written Opinion in the PCT process?
The Written Opinion serves multiple purposes in the Patent Cooperation Treaty (PCT) process, as outlined in MPEP 1845: “The international search report and written opinion together serve to inform the International Preliminary Examining Authority of the documents and arguments necessary to complete the relevant assessments if international preliminary examination is demanded, and to inform the…
Read MoreHow is the title of the invention determined for a PCT national phase application?
The title of the invention for a PCT national phase application is determined as follows: If an application data sheet (ADS) or preliminary amendment changing the title is not provided, the USPTO will use the title that appears on the first page of the description of: The published international application (if published in English under…
Read MoreWhat is the importance of the title in a PCT national phase application?
The title of the invention in a PCT national phase application is important for several reasons: It provides a concise description of the invention, helping examiners and the public quickly understand the subject matter. It is used in official USPTO documents, such as the filing receipt, which is an important record of the application. It…
Read MoreWhat are the rules regarding the furnishing of samples of deposited biological material in PCT applications?
The furnishing of samples of deposited biological material in PCT applications is governed by PCT Rule 13bis.6 and national laws. Key points include: Furnishing of samples is generally delayed until the start of the national phase. This delay ends when the applicant takes steps to enter the national phase or when international publication has effects…
Read MoreCan a designated Office refuse to recognize the restoration of the right of priority in a PCT application?
Yes, a designated Office can refuse to recognize the restoration of the right of priority in a PCT application under certain circumstances. MPEP 1828.01 provides guidance on this matter: “A designated Office may, subject to Rule 82ter.1(c), refuse to recognize the restoration if it finds that a requirement for restoration under Rule 26bis.3(a), (b)(i) or…
Read MoreCan the title of a PCT national phase application be changed after filing?
Yes, the title of a PCT national phase application can be changed after filing. There are two primary methods to change the title: Application Data Sheet (ADS): Applicants can submit an ADS with a new title. Preliminary Amendment: A preliminary amendment can be filed to change the title. The MPEP states: If applicant furnishes an…
Read MoreWhat happens if both an application data sheet and a preliminary amendment are submitted for a PCT national phase application?
When both an application data sheet (ADS) and a preliminary amendment are submitted for a PCT national phase application, the following rules apply: If the ADS and preliminary amendment are filed at different times, the later filed document will govern. As stated in the MPEP: If applicant submits both an application data sheet and a…
Read MoreWhat is a designated office in patent applications?
A designated office is a national patent office of a country that has been ‘designated’ by an applicant in an international patent application filed under the Patent Cooperation Treaty (PCT). In the context of MPEP 602.07, the United States Patent and Trademark Office (USPTO) acts as a designated office when an applicant enters the national…
Read More